<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2015.4021</article-id>
<article-id pub-id-type="publisher-id">or-34-02-0920</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>IM</surname><given-names>CHANG-NIM</given-names></name><xref rid="af1-or-34-02-0920" ref-type="aff">1</xref><xref rid="af2-or-34-02-0920" ref-type="aff">2</xref><xref rid="af3-or-34-02-0920" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>YUN</surname><given-names>HYE HYEON</given-names></name><xref rid="af1-or-34-02-0920" ref-type="aff">1</xref><xref rid="af2-or-34-02-0920" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>YOO</surname><given-names>HYUNG JAE</given-names></name><xref rid="af1-or-34-02-0920" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>PARK</surname><given-names>MYUNG-JIN</given-names></name><xref rid="af4-or-34-02-0920" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>LEE</surname><given-names>JEONG-HWA</given-names></name><xref rid="af1-or-34-02-0920" ref-type="aff">1</xref><xref rid="af2-or-34-02-0920" ref-type="aff">2</xref><xref rid="af3-or-34-02-0920" ref-type="aff">3</xref><xref ref-type="corresp" rid="c1-or-34-02-0920"/></contrib></contrib-group>
<aff id="af1-or-34-02-0920">
<label>1</label>Department of Biochemistry, College of Medicine, The Catholic university of korea, Seoul 137-701, Republic of korea</aff>
<aff id="af2-or-34-02-0920">
<label>2</label>Department of Cancer Research Institute, College of Medicine, The Catholic university of korea, Seoul 137-701, Republic of korea</aff>
<aff id="af3-or-34-02-0920">
<label>3</label>Cancer Evolution Research Center, College of Medicine, The Catholic university of korea, Seoul 137-701, Republic of korea</aff>
<aff id="af4-or-34-02-0920">
<label>4</label>Division of Radiation Cancer Research, korea Institute of Radiological and Medical Sciences, Seoul 139-706, Republic of korea</aff>
<author-notes>
<corresp id="c1-or-34-02-0920">Correspondence to: Professor Jeong-Hwa Lee, Department of Biochemistry, College of Medicine, The Catholic university of korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of korea, E-mail: <email>leejh@catholic.ac.kr</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>05</month>
<year>2015</year></pub-date>
<volume>34</volume>
<issue>2</issue>
<fpage>920</fpage>
<lpage>928</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>02</month>
<year>2015</year></date>
<date date-type="accepted">
<day>04</day>
<month>05</month>
<year>2015</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>More efficient isolation and identification of cancer stem cells (CSCs) would help in determining their fundamental roles in tumor biology. The classical tool for this purpose is anchorage-independent tumorsphere culture. We compared the effects of differently textured culture plates and serum deprivation on the acquisition of CSC properties of A172 glioblastoma cells. Cells were cultured on standard polystyrene-treated plates, ultra-low attachment, poly (2-hydroxyethyl methacrylate)-coated plates, and 1% agar-coated plates with 10% serum or in serum-free glioblastoma sphere medium (GBM). Based on mitochondrial reductase activity and subG1 proportions, non-adherent conditions had a greater impact on A172 cell viability than serum deprivation. Among the stemness-related genes, SOX-2 expression was significantly upregulated by serum deprivation under non-adherent conditions, while several epithelial-to-mesenchymal transition (EMT)-related genes were less dependent on serum. In addition, reactive oxygen species (ROS) accumulation in A172 cells was significantly increased in GBM under non-adherent conditions. Despite the correlation between SOX-2 induction and ROS accumulation, treatment with the ROS scavenger N-acetyl-l-cysteine did not prevent SOX-2 expression, suggesting that ROS accumulation is not an essential requirement for induction of SOX-2. Our results suggested that cultivation of cancer cells under conditions of serum deprivation in an anchorage-independent manner may enrich SOX-2-expressing CSC-like cells <italic>in vitro</italic>.</p></abstract>
<kwd-group>
<kwd>glioblastoma</kwd>
<kwd>serum deprivation</kwd>
<kwd>cancer stem cells</kwd>
<kwd>anchorage independence</kwd>
<kwd>SOX-2</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>A specific subpopulation of cancer cells, called cancer stem cells (CSCs), was recently proposed to be responsible for tumorigenesis and heterogeneity in primary cancers. This behavior was attributed to the extensive self-renewal activities and multipotent differentiation abilities of the CSCs (<xref rid="b1-or-34-02-0920" ref-type="bibr">1</xref>). Furthermore, CSCs have enhanced ability to invade surrounding tissues by undergoing epithelial-to-mesenchymal transition (EMT), which results in local and distant metastasis (<xref rid="b2-or-34-02-0920" ref-type="bibr">2</xref>). CSCs are also regarded as the cause of failure of chemotherapy and radiotherapy, leading to the recurrence of tumors (<xref rid="b3-or-34-02-0920" ref-type="bibr">3</xref>,<xref rid="b4-or-34-02-0920" ref-type="bibr">4</xref>). Therefore, the isolation and identification of CSCs <italic>in vitro</italic> are important and basic processes for the development of novel strategies to treat cancer <italic>in vivo</italic> by targeting CSCs.</p>
<p>Specifically, CSCs express a series of proteins including the sex-determining region Y-box 2 (SOX-2), octamer-binding transcription factor 4 (OCT-4), CD133 (also known as prom-inin-1, PROM1) and nestin (<xref rid="b5-or-34-02-0920" ref-type="bibr">5</xref>&#x02013;<xref rid="b10-or-34-02-0920" ref-type="bibr">10</xref>). CSCs also display enhanced ability for EMT and some transcription factors, such as TWIST, regulate EMT progress involved in metastasis (<xref rid="b11-or-34-02-0920" ref-type="bibr">11</xref>,<xref rid="b12-or-34-02-0920" ref-type="bibr">12</xref>). CD44 and CD133 surface marker expression have been widely used to isolate CSCs <italic>in vitro</italic> using specific antibodies and fluorescence-activated cell sorting (FACS) (<xref rid="b4-or-34-02-0920" ref-type="bibr">4</xref>,<xref rid="b13-or-34-02-0920" ref-type="bibr">13</xref>). However, the specificity and efficiency of CD133 in the enrichment of CSCs concerning stemness and self-renewal are complex and controversial (<xref rid="b10-or-34-02-0920" ref-type="bibr">10</xref>). For example, neither the expression of stemness genes nor the self-renewal capacities of CD133<sup>+</sup> and CD133<sup>&#x02212;</sup> cells were significantly different between freshly isolated glioma and glioma sphere cultures (<xref rid="b14-or-34-02-0920" ref-type="bibr">14</xref>). It has been demonstrated that CSCs can proliferate under serum-free culture conditions in a non-adherent manner to form sphere-like structures (<xref rid="b15-or-34-02-0920" ref-type="bibr">15</xref>&#x02013;<xref rid="b22-or-34-02-0920" ref-type="bibr">22</xref>). Thus, the culture of cancer cells under non-adherent conditions to allow sphere formation and/or evaluation of the expression of CSCs markers are the simplest and most convenient ways for enriching and identifying CSCs.</p>
<p>To induce anchorage-independent growth <italic>in vitro</italic>, various culture plate surface conditions have been applied with several supplemental factors, including epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) (<xref rid="b23-or-34-02-0920" ref-type="bibr">23</xref>). The surface of standard cell/tissue culture plates is negatively charged and hydrophilic, and is widely used with diverse cell cultures, while poly (2-hydroxyethyl methacrylate) (poly-HEMA)-coated, agar-coated, or ultra-low attachment plates have been used in <italic>in vitro</italic> studies to investigate anchorage-independent growth of cells including CSCs (<xref rid="b15-or-34-02-0920" ref-type="bibr">15</xref>&#x02013;<xref rid="b22-or-34-02-0920" ref-type="bibr">22</xref>). Agar plates are also used for anoikis, a form of programmed cell death that is induced by detachment of anchorage-dependent cells from the surrounding extracellular matrix (ECM) (<xref rid="b24-or-34-02-0920" ref-type="bibr">24</xref>&#x02013;<xref rid="b27-or-34-02-0920" ref-type="bibr">27</xref>). The ultra-low attachment surface has a neutral, hydrophilic hydrogel coating that reduces binding of attachment proteins. This surface is useful to maintain cells in a suspended, unattached state, thereby preventing stem cells from attachment-mediated differentiation and preventing anchorage-dependent cells from dividing (<xref rid="b28-or-34-02-0920" ref-type="bibr">28</xref>). Cells are usually grown as monolayers on normal culture plates where CSCs can proliferate and form spheres during long-term culture (~2&#x02013;3 weeks) under the three conditions noted above.</p>
<p>The malignant clinical outcome of glioblastoma is based on the aggressive invasion ability of cancer cells into the adjacent normal brain parenchyma, which eventually affects normal brain function despite standard therapies, such as radiotherapy (<xref rid="b21-or-34-02-0920" ref-type="bibr">21</xref>,<xref rid="b29-or-34-02-0920" ref-type="bibr">29</xref>). Therefore, defining these characteristics of CSCs of glioblastoma that survive or proliferate even under non-adherent conditions is critical in strategies for the treatment of glioblastoma. Silginer <italic>et al</italic> (<xref rid="b30-or-34-02-0920" ref-type="bibr">30</xref>) noted that poly-HEMA-mediated detachment promoted cell death of glioblastoma cells in a manner similar to integrin inhibition. Although Hong <italic>et al</italic> (<xref rid="b31-or-34-02-0920" ref-type="bibr">31</xref>) reported that the spherical characteristic of CSCs was observed for long-term cultured glioblastoma cells in medium with or without serum, the combined effects of different surface and media compositions with or without serum on the expression of genes involved in stemness and EMT are not well understood.</p>
<p>The present study explored how A172 glioblastoma cells behave under different culture conditions, i.e., serum deprivation and on plates with different surface types. We examined whether these culture conditions affected gene expression in relation to stemness- and EMT-related genes together with viability, cell cycle and ROS generation.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Cell culture</title>
<p>The human glioblastoma cell line A172 was purchased from American Type Culture Collection (ATCC; Manassas, VA, USA) and maintained in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM; HyClone, Logan, UT, USA) containing 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin at 37&#x000B0;C in a 5% CO<sub>2</sub> atmosphere. A172 cells were maintained in the above medium (Nm) and grown as monolayers on polystyrene-treated tissue culture plates (NP). The cells (1&#x000D7;10<sup>5</sup> cells) were cultured under the following conditions for 72 h: i) Nm or serum-free glioblastoma sphere medium (GBM) containing EGF (10 ng/ml) and bFGF (10 ng/ml) (both from R&amp;D Systems, Minneapolis, MN, USA) as previously described (<xref rid="b10-or-34-02-0920" ref-type="bibr">10</xref>,<xref rid="b23-or-34-02-0920" ref-type="bibr">23</xref>), and ii) NP, ultra-low attachment plates (UP; Corning, Tewksbury, MA, USA), 20 mg/ml poly-HEMA-coated plates (HP) and 1% agar-coated plates (AP). The morphology of cells was examined using an inverted phase contrast microscope (x200, magnification). To observe the effects of ROS scavengers on the induction of SOX-2, cells were treated for 72 h with 10 mM N-acetyl-l-cysteine (NAC; Sigma-Aldrich, St. Louis, MO, USA).</p></sec>
<sec>
<title>Plate preparation</title>
<p>Non-coated 6-well plates were coated with 1 ml of poly-HEMA (20 mg/ml; Sigma-Aldrich), dried overnight at room temperature, and washed twice with phosphate-buffered saline (PBS) before use. For the agar plates, 1% agar (Sigma-Aldrich) solution in PBS was added to 6-well plates and allowed to solidify for 1 h. The ultra-low attachment plates were purchased from Corning (Corning, NY, USA) and the polystyrene tissue culture plates were from SPL Life Sciences (Pocheon, Gyeonggi-do, korea).</p></sec>
<sec>
<title>Cell viability assay</title>
<p>Cell proliferation was assessed as a function of metabolic activity using an EZ-Cytox Cell Viability Assay kit (ItsBio, Seoul, korea). The assay is based on reduction of tetrazolium chloride to the water-soluble formazan by succinate-tetrazolium reductase, which forms part of the mitochondrial respiratory chain. After treatment with 20 <italic>&#x000B5;</italic>l/well, cells were incubated for 2 h at 37&#x000B0;C in a 5% CO<sub>2</sub> atmosphere. Absorbance was measured on a microplate reader (Bio-Rad 680; Bio-Rad, Hercules, CA, USA) at 450 nm. After subtraction of the background, the viability was determined as the ratio relative to the control and reported as the mean &#x000B1; standard error (SE).</p></sec>
<sec>
<title>Quantitative real-time polymerase chain reaction (qRT-PCR)</title>
<p>Total RNA was isolated using AccuZol (Bioneer, Daejeon, korea) and first-strand cDNA was synthesized by reverse transcription with 1 <italic>&#x000B5;</italic>g of total RNA using a ReverTra Ace qPCR kit (Toyobo, Osaka, Japan). Quantitative real-time PCR was performed to validate the expression level using SYBR<sup>&#x000AE;</sup> Premix Ex Taq&#x02122; (Takara Bio, Otsu, Shiga, Japan) with specific primers (<xref rid="tI-or-34-02-0920" ref-type="table">Table I</xref>) on an Applied Biosystems 7300 machine (Applied Biosystems, Carlsbad, CA, USA). The relative values for specific mRNA were calculated after normalization to the Ct value of &#x003B2;-actin in the same sample using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method.</p></sec>
<sec>
<title>Cell cycle analysis</title>
<p>Spheres were trypsinized for 5 min at 37&#x000B0;C in a 5% CO<sub>2</sub> atmosphere, neutralized with complete medium containing FBS, and centrifuged at 3,000 &#x000D7; g for 5 min. Single cells were then fixed with 70% ethanol at &#x02212;20&#x000B0;C overnight and incubated with a solution containing 5 <italic>&#x000B5;</italic>g/ml RNase A and 10 <italic>&#x000B5;</italic>g/ml propidium iodide (PI) (both from Sigma-Aldrich) for 30 min at room temperature. After washing twice with cold PBS, the cells were analyzed using a FACSCalibur (Becton-Dickinson, Bedford, MA, USA). Mean fluorescence intensities were obtained using CellQuest software (Becton-Dickinson).</p></sec>
<sec>
<title>Reactive oxygen species (ROS) measurement</title>
<p>Intracellular ROS levels in cells were measured using 5-(and-6)-car-boxy-2&#x02032;,7&#x02032;-dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCF-DA; Invitrogen, Carlsbad, CA, USA). Briefly, the cells were washed in PBS, trypsinized, and then neutralized with PBS-containing FBS. After two washes with PBS and further centrifugation, the cells were resuspended in PBS with 20<italic>&#x000B5;</italic>M DCF-DA and incubated for 20 min in the dark at 37&#x000B0;C. After the cells were resuspended in PBS, the fluorescence was measured using a FACSCalibur (excitation at 488 nm and emission at 515&#x02013;545 nm). The mean fluorescence intensity for 10,000 cells/sample was determined using CellQuest software.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Cells were washed twice with PBS and lysed with RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris-HCl and pH 8.0) with protease inhibitor (Roche Diagnostics, Penzberg, Germany) on ice for 30 min. Protein concentration was determined using a BCA Protein Assay kit (Pierce Biotechnology, Rockford, IL, USA). Equal amounts of protein were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membranes (Millipore, Billerica, MA, USA). The membranes were incubated for 1 h with 5% dried skim milk in TBST (20 mM Tris, 137 mM NaCl and 0.1% Tween 20) buffer and then incubated with primary antibodies to SOX-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), SOD1 (Enzo Life Sciences, Farmingdale, NY, USA) and SOD2 (Abcam, Cambridge Science Park, Cambridge, UK). Anti-&#x003B2;-actin antibody (Sigma-Aldrich) was used as an internal control. After incubation with horseradish peroxidase-conjugated secondary IgG (Santa Cruz Biotechnology), the immunoreactive bands were visualized on an enhanced chemiluminescence substrate (Thermo Fisher Scientific, Waltham, MA, USA). For quantification of the relative protein levels, densitometric analysis was carried out using Image J software (National Institutes of Health, Bethesda, MD, USA). The expression ratio relative to the control was calculated after normalization with the intensity of &#x003B2;-actin from each group.</p></sec>
<sec>
<title>Statistics</title>
<p>Student&#x02019;s t-test was used for comparison of differences between two groups. Each experiment was repeated at least three times. In all analyses, P&lt;0.05 was taken to indicate statistical significance.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Cells have distinct morphologies and adherence patterns under various cell culture conditions</title>
<p>A172 cells were cultured for 72 h in various culture environments differing in plate and media conditions, as described in the Materials and methods. The morphologies of cells from each group were examined under an inverted microscope. <xref rid="f1-or-34-02-0920" ref-type="fig">Fig. 1A</xref> shows that the A172 cells in Nm on NP (designated as controls) grew as a monolayer, while those in serum-free medium supplemented with growth factors (GBM, 10 ng/ml bFGF and EGF) on NP appeared loosely attached on the plates with some cells showing stellate projections. In contrast, cells cultured on the other plates (UP, HP and AP) in the Nm condition formed floating aggregates, while those cultured on UP and HP formed sphere-like colonies in GBM. To examine whether they could re-adhere to NP, cells or colonies from each group were dissociated using trypsin and seeded onto NP under the same media conditions. After 4 h, most cells cultured in Nm on NP, UP, HP and AP showed stable adherence to NP, whereas those cultured in GBM showed delayed adherence to NP irrespective of the previous plate conditions (<xref rid="f1-or-34-02-0920" ref-type="fig">Fig. 1B</xref>). After 24 h, most cells in Nm or GBM on the four surface types adhered to NP, but those cultured in GBM showed increased populations with elongated and fibroblast-like morphologies (<xref rid="f1-or-34-02-0920" ref-type="fig">Fig. 1C</xref>).</p></sec>
<sec>
<title>Cell viability decreased and subG1 proportion increased under conditions of serum-deprivation and non-adhesion</title>
<p>To examine cellular viability under the various conditions, equal numbers of cells from each condition were seeded on plates (1&#x000D7;10<sup>4</sup>/well) and incubated with tetrazolium chloride to monitor mitochondrial reductase activity. <xref rid="f2-or-34-02-0920" ref-type="fig">Fig. 2A</xref> shows that the relative viability of cells in GBM on NP (61&#x000B1;6.9%) was ~40% lower than that of the control. Moreover, cells in Nm and GBM on three types of plates (UP, HP and AP) had significantly lower activities than those in GBM on NP. Specifically, cellular activity on AP was the lowest among the conditions examined (9.3&#x000B1;5.32% in Nm and 9.39&#x000B1;3.88% in GBM). We also performed cell cycle analysis by flow cytometry after staining the cells with PI (<xref rid="f2-or-34-02-0920" ref-type="fig">Fig. 2B</xref>). Compared with control cells (2.05&#x000B1;0.03%), there was a ~10% increase in the subG1 proportion of cells under GMB culture conditions (GBM/NP, 11.4&#x000B1;3.2%) together with decreased G2/M phase. However, on the other plates, incubation in GBM did not increase the subG1 proportion (Nm/UP, 19.88&#x000B1;3.96%; GBM/UP, 14.64&#x000B1;8.12%; Nm/HP, 9.16&#x000B1;2.22%; GBM/HP, 8.82&#x000B1;3.33%; Nm/AP, 20.13&#x000B1;9.83%; and GBM/AP, 17.76&#x000B1;6.58%).</p></sec>
<sec>
<title>SOX-2 mRNA levels increased markedly in GBM on UP and HP</title>
<p>To determine whether combined culture conditions affected the self-renewal and EMT abilities of these cells, the expression levels of four stem cell markers and seven EMT-related markers were examined by real-time PCR using specific primers (<xref rid="tI-or-34-02-0920" ref-type="table">Table I</xref>). Compared with the control, SOX-2 mRNA levels showed the greatest increase in GBM on both UP and HP (fold-change: 321 and 369, respectively). CD133 expression also increased in GBM on UP and HP but to a lesser extent, which was not statistically significant. Among the EMT markers, SNAIL expression decreased on three plate types (UP, HP and AP). The mRNA levels of the other EMT markers appeared to be dependent on the plate type rather than the medium type (<xref rid="f3-or-34-02-0920" ref-type="fig">Fig. 3</xref>).</p></sec>
<sec>
<title>Both serum-deprivation and non-adherent conditions enhanced ROS accumulation</title>
<p>The effects of different culture conditions on ROS levels were investigated because ROS may be an important factor in regulation of stem cells and the chemoresistance of cancer stem cells (<xref rid="b32-or-34-02-0920" ref-type="bibr">32</xref>&#x02013;<xref rid="b34-or-34-02-0920" ref-type="bibr">34</xref>). Performance was assessed by the conversion of non-fluorescent H<sub>2</sub>DCF to the fluorescent form (<xref rid="b35-or-34-02-0920" ref-type="bibr">35</xref>). <xref rid="f4-or-34-02-0920" ref-type="fig">Fig. 4</xref> shows that the level of ROS generation in the cells cultured on UP or HP in normal medium was about double that in those cultured on normal plates. Serum deprivation GBM on UP or HP further increased ROS generation by 8-fold. Interestingly, ROS levels from cells cultured in both Nm and GBM on AP were 6- and 8-fold higher, respectively, than the control. These data indicate that the effect of serum deprivation on ROS accumulation is greater than that of the non-adherent condition.</p></sec>
<sec>
<title>SOD2 expression was induced under non-adherent conditions</title>
<p>As ROS generation was increased by serum deprivation, which was also effective for SOX-2 induction, we examined whether alterations in SOD1 and SOD2 expression were responsible for ROS accumulation and SOX-2 induction under serum deprivation or non-adherent conditions. Western blotting indicated that the level of SOX-2 expression was higher in the GBM condition than in normal medium on all four plate types, which was similar to the mRNA profile (<xref rid="f5-or-34-02-0920" ref-type="fig">Fig. 5A</xref>). While SOD1 expression showed no prominent pattern with respect to serum deprivation or plate condition, the SOD2 expression profile exhibited an inverse relationship with that of SOX-2 (<xref rid="f5-or-34-02-0920" ref-type="fig">Fig. 5B and C</xref>). However, with the exception of values from UP in Nm or GBM, the correlations were not statistically significant. Dot plot analysis was performed using the mean values of the SOX-2 and SOD2 protein levels. <xref rid="f5-or-34-02-0920" ref-type="fig">Fig. 5D</xref> shows that the two protein values from each group could be classified into a significantly larger SOX-2-expressing group (gray-dotted circle; GBM on three plate types) and a SOD2-expressing group (black ellipse; Nm on UP, HP and AP). SOX-2 expression was shown to be dependent on the GBM condition, while SOD2 expression was dependent on the non-adherent conditions. Finally, cells were treated with NAC, a general ROS scavenger, to determine whether NAC could reverse the SOX-2 induction observed under our culture conditions. Western blotting was performed using antibodies to SOX-2, SOD1, and SOD2 after treatment with 10 mM NAC under the same conditions for 72 h. <xref rid="f6-or-34-02-0920" ref-type="fig">Fig. 6</xref> shows that NAC treatment did not block the induction of SOX-2 or SOD2, suggesting that it was independent of ROS. Data from qRT-PCR analyses also revealed no significant recovery of SOX-2 with NAC treatment (data not shown).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The isolation and enrichment of CSCs <italic>in vitro</italic> are important for targeting strategies and drug screening for anticancer therapy. It would be beneficial to be able to characterize cancer cells under different culture conditions <italic>in vitro</italic> to better understand the features of CSCs. This study examined the combined effects of serum deprivation and culture plate surface type on the morphology, viability, and markers for stemness and EMT in A172 glioblastoma cells. These cells were previously shown to have aggressive migration ability and ROS accumulation in response to appropriate stimuli (<xref rid="b36-or-34-02-0920" ref-type="bibr">36</xref>,<xref rid="b37-or-34-02-0920" ref-type="bibr">37</xref>).</p>
<p>In the presence of serum, A172 cells grew as a monolayer while those on UP, HP and AP did not attach to the bottom and formed colonies, which led to decreased viability and increased apoptosis (<xref rid="f1-or-34-02-0920" ref-type="fig">Figs. 1A</xref> and <xref rid="f2-or-34-02-0920" ref-type="fig">2A and B</xref>). However, most of the cells from each plate regained the adhesion ability and apparent viability when allowed to re-adhere to NP after 72 h of culture on each plate. These observations indicated that the interaction with the extracellular matrix (ECM) is an important prerequisite for the survival of cancer cells (<xref rid="f1-or-34-02-0920" ref-type="fig">Fig. 1A&#x02013;C</xref>). The results also demonstrated that incubation of cells on various plates in serum-free GBM did not further affect the viability, except on NP, but delayed the re-adhesion on NP with an appearance of more elongated phenotypes after 72 h of culture. This delay is attributed to vitronectin and fibronectin in serum (<xref rid="b38-or-34-02-0920" ref-type="bibr">38</xref>). It is plausible that the serum-free condition is less critical to the maintenance of viability but is more effective than the non-adherent condition for enrichment of cancer stem cell-like cells.</p>
<p>Our results based on the mitochondrial reductase activity and subG1 fractions were inconsistent for the evaluation of cell viability. This indicated that the reduced viability estimated by mitochondrial reductase activity did not necessarily represent apoptotic cells but rather the metabolically inactive status, which could be stimulated by environmental changes. These results also reinforce the heterogeneous and dynamic nature of cancer cells, which can show different responses under these harsh conditions. It is significant that cell incubation on AP exhibited the lowest activity in mitochondrial reductase and highest proportions of subG1 and highest ROS accumulation among the culture plate conditions, and that serum deprivation did not have considerable effects. Therefore, culture on AP rather than HP in the presence of serum seemed be the most efficient way to induce anoikis, which is an important defense mechanism for preventing the anchorage-independent survival of tumor cells (<xref rid="b39-or-34-02-0920" ref-type="bibr">39</xref>).</p>
<p>SOX-2 was significantly increased by the GBM condition, and was especially prominent on UP and HP at both mRNA and protein levels (<xref rid="f3-or-34-02-0920" ref-type="fig">Figs. 3B</xref> and <xref rid="f5-or-34-02-0920" ref-type="fig">5</xref>). These results support the importance of serum-free conditions on enrichment of CSCs. Our findings were consistent with the previous report that serum deprivation-induced bone marrow stem cells show upregulated expression of stemness-related protein, such as SOX-2 (<xref rid="b40-or-34-02-0920" ref-type="bibr">40</xref>).</p>
<p>SOX-2 has been suggested to be a marker of stem cells (<xref rid="b7-or-34-02-0920" ref-type="bibr">7</xref>) and CSCs (<xref rid="b41-or-34-02-0920" ref-type="bibr">41</xref>,<xref rid="b42-or-34-02-0920" ref-type="bibr">42</xref>). Thus, culture of cancer cells under conditions of serum deprivation on UP or HP could be useful for the isolation and enrichment of SOX-2-expressing CSCs. The expression of some EMT-related genes, such as ZEB2, TWIST and VIMENTIN, was induced by non-adherent conditions rather than by serum deprivation. However, these genes were expressed with different statistical significances, which suggested that the acquisition of both stemness and EMT properties could be provided to cancer cells only by very subtle and complex changes in the environment.</p>
<p><xref rid="f4-or-34-02-0920" ref-type="fig">Fig. 4</xref> shows that significantly higher ROS levels were observed in GBM on NP as well as on non-adherent plates (UP, HP and AP). The higher levels seemed to be more dependent on serum deprivation than on the presence of a non-adherent surface. ROS is a critical factor for maintaining stemness by the expression of SOX-2 (<xref rid="b43-or-34-02-0920" ref-type="bibr">43</xref>), and SOD2 promotes migration and invasion and protects cells from ROS-mediated cell death (<xref rid="b44-or-34-02-0920" ref-type="bibr">44</xref>&#x02013;<xref rid="b46-or-34-02-0920" ref-type="bibr">46</xref>). Therefore, we hypothesized that a ROS scavenger would block SOX-2 induction under our cell culture conditions. NAC treatment, however, did not prevent SOX-2 levels at the mRNA (data not shown) or protein level (<xref rid="f6-or-34-02-0920" ref-type="fig">Fig. 6A</xref>). These results indicated that induction of SOX-2 was not dependent on ROS under our conditions. However, the induction profiles of SOX-2 with SOD2 under different culture conditions suggested some influence of SOD2 on ROS and SOX-2 induction. This indication merits further investigation.</p>
<p>Although Sauerzweig <italic>et al</italic> (<xref rid="b40-or-34-02-0920" ref-type="bibr">40</xref>) suggested that serum deprivation is an enrichment process for CSCs, growth factors are also required to maintain the self-renewal of brain tumor stem cells (<xref rid="b23-or-34-02-0920" ref-type="bibr">23</xref>). Therefore, we could not exclude the effects of the growth factors EGF and bFGF, which were included in GBM in the present study, on the expression of SOX-2 as well as on ROS accumulation. Another limitation of our study was that the viability and expression of markers for CSC and EMT were examined after only 72 h of incubation; this is probably insufficient time to fully select the CSCs. Therefore, the effects of serum deprivation only and long-term culture on different plate conditions should also be examined to determine the most efficient culture conditions for CSCs.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This research was supported by the Basic Science Research Program through the National Research Foundation of korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2014R1A1A1006961 and 2012R1A5A2047939).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-or-34-02-0920"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>CT</given-names></name><name><surname>Guzman</surname><given-names>ML</given-names></name><name><surname>Noble</surname><given-names>M</given-names></name></person-group><article-title>Cancer stem cells</article-title><source>N Engl J Med</source><volume>355</volume><fpage>1253</fpage><lpage>1261</lpage><year>2006</year><pub-id pub-id-type="doi">10.1056/NEJMra061808</pub-id><pub-id pub-id-type="pmid">16990388</pub-id></element-citation></ref>
<ref id="b2-or-34-02-0920"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Cancer stem cell: A rogue responsible for tumor development and metastasis</article-title><source>Indian J Cancer</source><volume>51</volume><fpage>282</fpage><lpage>289</lpage><year>2014</year><pub-id pub-id-type="doi">10.4103/0019-509X.146794</pub-id><pub-id pub-id-type="pmid">25494123</pub-id></element-citation></ref>
<ref id="b3-or-34-02-0920"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinn</surname><given-names>SB</given-names></name><name><surname>Darr</surname><given-names>OA</given-names></name><name><surname>Peters</surname><given-names>RD</given-names></name><name><surname>Prince</surname><given-names>ME</given-names></name></person-group><article-title>The role of head and neck squamous cell carcinoma cancer stem cells in tumori-genesis, metastasis, and treatment failure</article-title><source>Front Endocrinol (Lausanne)</source><volume>3</volume><fpage>90</fpage><year>2012</year></element-citation></ref>
<ref id="b4-or-34-02-0920"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahlberg</surname><given-names>SH</given-names></name><name><surname>Spiegelberg</surname><given-names>D</given-names></name><name><surname>Glimelius</surname><given-names>B</given-names></name><name><surname>Stenerl&#x000F6;w</surname><given-names>B</given-names></name><name><surname>Nestor</surname><given-names>M</given-names></name></person-group><article-title>Evaluation of cancer stem cell markers CD133, CD44, CD24: Association with AkT isoforms and radiation resistance in colon cancer cells</article-title><source>PLoS One</source><volume>9</volume><fpage>e94621</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pone.0094621</pub-id><pub-id pub-id-type="pmid">24760019</pub-id><pub-id pub-id-type="pmcid">3997403</pub-id></element-citation></ref>
<ref id="b5-or-34-02-0920"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name></person-group><article-title>Expression of glioma stem cell marker CD133 and O<sup>6</sup>-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas</article-title><source>Oncol Rep</source><volume>26</volume><fpage>1305</fpage><lpage>1313</lpage><year>2011</year><pub-id pub-id-type="pmid">21769436</pub-id></element-citation></ref>
<ref id="b6-or-34-02-0920"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>WL</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name></person-group><article-title>Sox2: Masterminding the root of cancer</article-title><source>Cancer Cell</source><volume>26</volume><fpage>3</fpage><lpage>5</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.ccr.2014.06.024</pub-id><pub-id pub-id-type="pmid">25026204</pub-id></element-citation></ref>
<ref id="b7-or-34-02-0920"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Choo</surname><given-names>AB</given-names></name><name><surname>Nai-Dy</surname><given-names>W</given-names></name><name><surname>Heng-Phon</surname><given-names>T</given-names></name><name><surname>Oh</surname><given-names>SK</given-names></name></person-group><article-title>Knockdown of Oct-4 or Sox-2 attenuates neurogenesis of mouse embryonic stem cells</article-title><source>Stem Cells Dev</source><volume>16</volume><fpage>413</fpage><lpage>420</lpage><year>2007</year><pub-id pub-id-type="doi">10.1089/scd.2006.0099</pub-id><pub-id pub-id-type="pmid">17610371</pub-id></element-citation></ref>
<ref id="b8-or-34-02-0920"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiou</surname><given-names>SH</given-names></name><name><surname>Yu</surname><given-names>CC</given-names></name><name><surname>Huang</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Liu</surname><given-names>CJ</given-names></name><name><surname>Tsai</surname><given-names>TH</given-names></name><name><surname>Chou</surname><given-names>SH</given-names></name><name><surname>Chien</surname><given-names>CS</given-names></name><name><surname>Ku</surname><given-names>HH</given-names></name><name><surname>Lo</surname><given-names>JF</given-names></name></person-group><article-title>Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma</article-title><source>Clin Cancer Res</source><volume>14</volume><fpage>4085</fpage><lpage>4095</lpage><year>2008</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-4404</pub-id><pub-id pub-id-type="pmid">18593985</pub-id></element-citation></ref>
<ref id="b9-or-34-02-0920"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiwata</surname><given-names>T</given-names></name><name><surname>Teduka</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Kawahara</surname><given-names>K</given-names></name><name><surname>Matsuda</surname><given-names>Y</given-names></name><name><surname>Naito</surname><given-names>Z</given-names></name></person-group><article-title>Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas</article-title><source>Oncol Rep</source><volume>26</volume><fpage>91</fpage><lpage>99</lpage><year>2011</year><pub-id pub-id-type="pmid">21503585</pub-id></element-citation></ref>
<ref id="b10-or-34-02-0920"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>MJ</given-names></name><name><surname>Rho</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Jung</surname><given-names>JE</given-names></name><name><surname>Jin</surname><given-names>YB</given-names></name><name><surname>Ko</surname><given-names>YG</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Park</surname><given-names>MJ</given-names></name></person-group><article-title>Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells</article-title><source>Oncogene</source><volume>32</volume><fpage>209</fpage><lpage>221</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/onc.2012.37</pub-id></element-citation></ref>
<ref id="b11-or-34-02-0920"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>MA</given-names></name><name><surname>Geiger</surname><given-names>TR</given-names></name><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Gitelman</surname><given-names>I</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name></person-group><article-title>A Twist-Snail axis critical for TrkB-induced epithelial-mesen-chymal transition-like transformation, anoikis resistance, and metastasis</article-title><source>Mol Cell Biol</source><volume>29</volume><fpage>3722</fpage><lpage>3737</lpage><year>2009</year><pub-id pub-id-type="doi">10.1128/MCB.01164-08</pub-id><pub-id pub-id-type="pmid">19414595</pub-id><pub-id pub-id-type="pmcid">2698746</pub-id></element-citation></ref>
<ref id="b12-or-34-02-0920"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name></person-group><article-title>Multilayer control of the EMT master regulators</article-title><source>Oncogene</source><volume>33</volume><fpage>1755</fpage><lpage>1763</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/onc.2013.128</pub-id></element-citation></ref>
<ref id="b13-or-34-02-0920"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Clarke</surname><given-names>ID</given-names></name><name><surname>Terasaki</surname><given-names>M</given-names></name><name><surname>Bonn</surname><given-names>VE</given-names></name><name><surname>Hawkins</surname><given-names>C</given-names></name><name><surname>Squire</surname><given-names>J</given-names></name><name><surname>Dirks</surname><given-names>PB</given-names></name></person-group><article-title>Identification of a cancer stem cell in human brain tumors</article-title><source>Cancer Res</source><volume>63</volume><fpage>5821</fpage><lpage>5828</lpage><year>2003</year><pub-id pub-id-type="pmid">14522905</pub-id></element-citation></ref>
<ref id="b14-or-34-02-0920"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cl&#x000E9;ment</surname><given-names>V</given-names></name><name><surname>Dutoit</surname><given-names>V</given-names></name><name><surname>Marino</surname><given-names>D</given-names></name><name><surname>Dietrich</surname><given-names>PY</given-names></name><name><surname>Radovanovic</surname><given-names>I</given-names></name></person-group><article-title>Limits of CD133 as a marker of glioma self-renewing cells</article-title><source>Int J Cancer</source><volume>125</volume><fpage>244</fpage><lpage>248</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/ijc.24352</pub-id><pub-id pub-id-type="pmid">19350631</pub-id></element-citation></ref>
<ref id="b15-or-34-02-0920"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>MA</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>P</given-names></name><name><surname>LaPushin</surname><given-names>R</given-names></name><name><surname>Koul</surname><given-names>D</given-names></name><name><surname>Bookstein</surname><given-names>R</given-names></name><name><surname>Stokoe</surname><given-names>D</given-names></name><name><surname>Yung</surname><given-names>WK</given-names></name><etal/></person-group><article-title>Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis</article-title><source>Cancer Res</source><volume>58</volume><fpage>5285</fpage><lpage>5290</lpage><year>1998</year><pub-id pub-id-type="pmid">9850049</pub-id></element-citation></ref>
<ref id="b16-or-34-02-0920"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minett</surname><given-names>TW</given-names></name><name><surname>Tighe</surname><given-names>BJ</given-names></name><name><surname>Lydon</surname><given-names>MJ</given-names></name><name><surname>Rees</surname><given-names>DA</given-names></name></person-group><article-title>Requirements for cell spreading on polyHEMA coated culture substrates</article-title><source>Cell Biol Int Rep</source><volume>8</volume><fpage>151</fpage><lpage>159</lpage><year>1984</year><pub-id pub-id-type="doi">10.1016/0309-1651(84)90082-1</pub-id><pub-id pub-id-type="pmid">6713548</pub-id></element-citation></ref>
<ref id="b17-or-34-02-0920"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiucci</surname><given-names>G</given-names></name><name><surname>Ravid</surname><given-names>D</given-names></name><name><surname>Reich</surname><given-names>R</given-names></name><name><surname>Liscovitch</surname><given-names>M</given-names></name></person-group><article-title>Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells</article-title><source>Oncogene</source><volume>21</volume><fpage>2365</fpage><lpage>2375</lpage><year>2002</year><pub-id pub-id-type="doi">10.1038/sj.onc.1205300</pub-id><pub-id pub-id-type="pmid">11948420</pub-id></element-citation></ref>
<ref id="b18-or-34-02-0920"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>TX</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Sano</surname><given-names>D</given-names></name><name><surname>Jasser</surname><given-names>SA</given-names></name><name><surname>Brennan</surname><given-names>RG</given-names></name><name><surname>Myers</surname><given-names>JN</given-names></name></person-group><article-title>Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells</article-title><source>Laryngoscope</source><volume>123</volume><fpage>1416</fpage><lpage>1423</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/lary.23846</pub-id><pub-id pub-id-type="pmid">23625637</pub-id><pub-id pub-id-type="pmcid">3664100</pub-id></element-citation></ref>
<ref id="b19-or-34-02-0920"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Casal</surname><given-names>R</given-names></name><name><surname>Bhattacharya</surname><given-names>C</given-names></name><name><surname>Ganesh</surname><given-names>N</given-names></name><name><surname>Bailey</surname><given-names>L</given-names></name><name><surname>Basse</surname><given-names>P</given-names></name><name><surname>Gibson</surname><given-names>M</given-names></name><name><surname>Epperly</surname><given-names>M</given-names></name><name><surname>Levina</surname><given-names>V</given-names></name></person-group><article-title>Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes</article-title><source>Mol Cancer</source><volume>12</volume><fpage>94</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1476-4598-12-94</pub-id><pub-id pub-id-type="pmid">23947765</pub-id><pub-id pub-id-type="pmcid">3751356</pub-id></element-citation></ref>
<ref id="b20-or-34-02-0920"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Vodopyanov</surname><given-names>D</given-names></name><name><surname>Imai</surname><given-names>A</given-names></name><name><surname>Helman</surname><given-names>JI</given-names></name><name><surname>Prince</surname><given-names>ME</given-names></name><name><surname>Wicha</surname><given-names>MS</given-names></name><name><surname>N&#x000F6;r</surname><given-names>JE</given-names></name></person-group><article-title>Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells</article-title><source>Cancer Res</source><volume>70</volume><fpage>9969</fpage><lpage>9978</lpage><year>2010</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1712</pub-id><pub-id pub-id-type="pmid">21098716</pub-id><pub-id pub-id-type="pmcid">3058885</pub-id></element-citation></ref>
<ref id="b21-or-34-02-0920"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesanakurti</surname><given-names>D</given-names></name><name><surname>Chetty</surname><given-names>C</given-names></name><name><surname>Rajasekhar Maddirela</surname><given-names>D</given-names></name><name><surname>Gujrati</surname><given-names>M</given-names></name><name><surname>Rao</surname><given-names>JS</given-names></name></person-group><article-title>Functional cooperativity by direct interaction between PAk4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma</article-title><source>Cell Death Dis</source><volume>3</volume><fpage>e445</fpage><year>2012</year><pub-id pub-id-type="doi">10.1038/cddis.2012.182</pub-id><pub-id pub-id-type="pmid">23254288</pub-id><pub-id pub-id-type="pmcid">3542618</pub-id></element-citation></ref>
<ref id="b22-or-34-02-0920"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>BL</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Dong</surname><given-names>MM</given-names></name></person-group><article-title>Cancer stem-like side population cells in the human nasopharyngeal carcinoma cell line CNE-2 possess epithelial mesenchymal transition properties in association with metastasis</article-title><source>Oncol Rep</source><volume>28</volume><fpage>241</fpage><lpage>247</lpage><year>2012</year><pub-id pub-id-type="pmid">22552840</pub-id></element-citation></ref>
<ref id="b23-or-34-02-0920"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestereva</surname><given-names>E</given-names></name><name><surname>Kanakasabai</surname><given-names>S</given-names></name><name><surname>Bright</surname><given-names>JJ</given-names></name></person-group><article-title>PPAR&#x003B3; agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells</article-title><source>Br J Cancer</source><volume>106</volume><fpage>1702</fpage><lpage>1712</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/bjc.2012.161</pub-id><pub-id pub-id-type="pmid">22531638</pub-id><pub-id pub-id-type="pmcid">3349185</pub-id></element-citation></ref>
<ref id="b24-or-34-02-0920"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>SM</given-names></name><name><surname>Screaton</surname><given-names>RA</given-names></name></person-group><article-title>Anoikis mechanisms</article-title><source>Curr Opin Cell Biol</source><volume>13</volume><fpage>555</fpage><lpage>562</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0955-0674(00)00251-9</pub-id><pub-id pub-id-type="pmid">11544023</pub-id></element-citation></ref>
<ref id="b25-or-34-02-0920"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossmann</surname><given-names>J</given-names></name></person-group><article-title>Molecular mechanisms of &#x02018;detachment-induced apoptosis &#x02013; Anoikis&#x02019;</article-title><source>Apoptosis</source><volume>7</volume><fpage>247</fpage><lpage>260</lpage><year>2002</year><pub-id pub-id-type="doi">10.1023/A:1015312119693</pub-id><pub-id pub-id-type="pmid">11997669</pub-id></element-citation></ref>
<ref id="b26-or-34-02-0920"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Rescorla</surname><given-names>FJ</given-names></name></person-group><article-title>Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities</article-title><source>Cell Signal</source><volume>24</volume><fpage>393</fpage><lpage>401</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.cellsig.2011.10.005</pub-id></element-citation></ref>
<ref id="b27-or-34-02-0920"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>ZC</given-names></name></person-group><article-title>Signalling mechanisms of anoikis</article-title><source>Histol Histopathol</source><volume>19</volume><fpage>973</fpage><lpage>983</lpage><year>2004</year><pub-id pub-id-type="pmid">15168359</pub-id></element-citation></ref>
<ref id="b28-or-34-02-0920"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Horbett</surname><given-names>TA</given-names></name></person-group><article-title>The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces</article-title><source>J Biomed Mater Res</source><volume>57</volume><fpage>336</fpage><lpage>345</lpage><year>2001</year><pub-id pub-id-type="doi">10.1002/1097-4636(20011205)57:3&lt;336::AID-JBM1176&gt;3.0.CO;2-E</pub-id><pub-id pub-id-type="pmid">11523028</pub-id></element-citation></ref>
<ref id="b29-or-34-02-0920"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardee</surname><given-names>ME</given-names></name><name><surname>Marciscano</surname><given-names>AE</given-names></name><name><surname>Medina-Ramirez</surname><given-names>CM</given-names></name><name><surname>Zagzag</surname><given-names>D</given-names></name><name><surname>Narayana</surname><given-names>A</given-names></name><name><surname>Lonning</surname><given-names>SM</given-names></name><name><surname>Barcellos-Hoff</surname><given-names>MH</given-names></name></person-group><article-title>Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-&#x003B2;</article-title><source>Cancer Res</source><volume>72</volume><fpage>4119</fpage><lpage>4129</lpage><year>2012</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-0546</pub-id><pub-id pub-id-type="pmid">22693253</pub-id><pub-id pub-id-type="pmcid">3538149</pub-id></element-citation></ref>
<ref id="b30-or-34-02-0920"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silginer</surname><given-names>M</given-names></name><name><surname>Weller</surname><given-names>M</given-names></name><name><surname>Ziegler</surname><given-names>U</given-names></name><name><surname>Roth</surname><given-names>P</given-names></name></person-group><article-title>Integrin inhibition promotes atypical anoikis in glioma cells</article-title><source>Cell Death Dis</source><volume>5</volume><fpage>e1012</fpage><year>2014</year><pub-id pub-id-type="doi">10.1038/cddis.2013.543</pub-id><pub-id pub-id-type="pmid">24457956</pub-id><pub-id pub-id-type="pmcid">4040659</pub-id></element-citation></ref>
<ref id="b31-or-34-02-0920"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Chedid</surname><given-names>K</given-names></name><name><surname>Kalkanis</surname><given-names>SN</given-names></name></person-group><article-title>Glioblastoma cell line-derived spheres in serum-containing medium versus serum-free medium: A comparison of cancer stem cell properties</article-title><source>Int J Oncol</source><volume>41</volume><fpage>1693</fpage><lpage>1700</lpage><year>2012</year><pub-id pub-id-type="pmid">22922964</pub-id></element-citation></ref>
<ref id="b32-or-34-02-0920"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigarella</surname><given-names>CL</given-names></name><name><surname>Liang</surname><given-names>R</given-names></name><name><surname>Ghaffari</surname><given-names>S</given-names></name></person-group><article-title>Stem cells and the impact of ROS signaling</article-title><source>Development</source><volume>141</volume><fpage>4206</fpage><lpage>4218</lpage><year>2014</year><pub-id pub-id-type="doi">10.1242/dev.107086</pub-id><pub-id pub-id-type="pmid">25371358</pub-id><pub-id pub-id-type="pmcid">4302918</pub-id></element-citation></ref>
<ref id="b33-or-34-02-0920"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Shibuya</surname><given-names>K</given-names></name><name><surname>Seino</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name><name><surname>Seino</surname><given-names>S</given-names></name><name><surname>Yoshioka</surname><given-names>T</given-names></name><name><surname>Kitanaka</surname><given-names>C</given-names></name></person-group><article-title>JNk suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells</article-title><source>Oncotarget</source><volume>6</volume><fpage>458</fpage><lpage>470</lpage><year>2014</year><pub-id pub-id-type="pmid">25473894</pub-id><pub-id pub-id-type="pmcid">4381607</pub-id></element-citation></ref>
<ref id="b34-or-34-02-0920"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali Azouaou</surname><given-names>S</given-names></name><name><surname>Emhemmed</surname><given-names>F</given-names></name><name><surname>Idris-khodja</surname><given-names>N</given-names></name><name><surname>Lobstein</surname><given-names>A</given-names></name><name><surname>Schini-kerth</surname><given-names>V</given-names></name><name><surname>Muller</surname><given-names>CD</given-names></name><name><surname>Fuhrmann</surname><given-names>G</given-names></name></person-group><article-title>Selective ROS-dependent p53-associated anticancer effects of the hypoxoside derivative rooperol on human teratocarcinomal cancer stem-like cells</article-title><source>Invest New Drugs</source><volume>33</volume><fpage>64</fpage><lpage>74</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10637-014-0182-6</pub-id><pub-id pub-id-type="pmid">25404486</pub-id></element-citation></ref>
<ref id="b35-or-34-02-0920"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myhre</surname><given-names>O</given-names></name><name><surname>Andersen</surname><given-names>JM</given-names></name><name><surname>Aarnes</surname><given-names>H</given-names></name><name><surname>Fonnum</surname><given-names>F</given-names></name></person-group><article-title>Evaluation of the probes 2&#x02032;,7&#x02032;-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation</article-title><source>Biochem Pharmacol</source><volume>65</volume><fpage>1575</fpage><lpage>1582</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0006-2952(03)00083-2</pub-id><pub-id pub-id-type="pmid">12754093</pub-id></element-citation></ref>
<ref id="b36-or-34-02-0920"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YD</given-names></name><name><surname>Cui</surname><given-names>MN</given-names></name><name><surname>Yoon</surname><given-names>HH</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Oh</surname><given-names>IH</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-&#x003BA;B mediated activation of MMP-9</article-title><source>BMB Rep</source><volume>47</volume><fpage>262</fpage><lpage>267</lpage><year>2014</year><pub-id pub-id-type="doi">10.5483/BMBRep.2014.47.5.172</pub-id><pub-id pub-id-type="pmcid">4163862</pub-id></element-citation></ref>
<ref id="b37-or-34-02-0920"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>HJ</given-names></name><name><surname>Im</surname><given-names>CN</given-names></name><name><surname>Youn</surname><given-names>DY</given-names></name><name><surname>Yun</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Bis is induced by oxidative stress via activation of HSF1</article-title><source>korean J Physiol Pharmacol</source><volume>18</volume><fpage>403</fpage><lpage>409</lpage><year>2014</year><pub-id pub-id-type="doi">10.4196/kjpp.2014.18.5.403</pub-id><pub-id pub-id-type="pmid">25352760</pub-id><pub-id pub-id-type="pmcid">4211124</pub-id></element-citation></ref>
<ref id="b38-or-34-02-0920"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayman</surname><given-names>EG</given-names></name><name><surname>Pierschbacher</surname><given-names>MD</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Ruoslahti</surname><given-names>E</given-names></name></person-group><article-title>Vitronectin - a major cell attachment-promoting protein in fetal bovine serum</article-title><source>Exp Cell Res</source><volume>160</volume><fpage>245</fpage><lpage>258</lpage><year>1985</year><pub-id pub-id-type="doi">10.1016/0014-4827(85)90173-9</pub-id><pub-id pub-id-type="pmid">2412864</pub-id></element-citation></ref>
<ref id="b39-or-34-02-0920"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoli</surname><given-names>P</given-names></name><name><surname>Giannoni</surname><given-names>E</given-names></name><name><surname>Chiarugi</surname><given-names>P</given-names></name></person-group><article-title>Anoikis molecular pathways and its role in cancer progression</article-title><source>Biochim Biophys Acta</source><volume>1833</volume><fpage>3481</fpage><lpage>3498</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.bbamcr.2013.06.026</pub-id><pub-id pub-id-type="pmid">23830918</pub-id></element-citation></ref>
<ref id="b40-or-34-02-0920"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauerzweig</surname><given-names>S</given-names></name><name><surname>Munsch</surname><given-names>T</given-names></name><name><surname>Lessmann</surname><given-names>V</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name><name><surname>Braun</surname><given-names>H</given-names></name></person-group><article-title>A population of serum deprivation-induced bone marrow stem cells (SD-BMSC) expresses marker typical for embryonic and neural stem cells</article-title><source>Exp Cell Res</source><volume>315</volume><fpage>50</fpage><lpage>66</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.yexcr.2008.10.007</pub-id></element-citation></ref>
<ref id="b41-or-34-02-0920"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>GQ</given-names></name><name><surname>Chen</surname><given-names>DB</given-names></name><name><surname>Wang</surname><given-names>BQ</given-names></name><name><surname>Zhang</surname><given-names>LS</given-names></name></person-group><article-title>Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines</article-title><source>Oncol Lett</source><volume>4</volume><fpage>1264</fpage><lpage>1268</lpage><year>2012</year><pub-id pub-id-type="pmid">23197999</pub-id><pub-id pub-id-type="pmcid">3506717</pub-id></element-citation></ref>
<ref id="b42-or-34-02-0920"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favaro</surname><given-names>R</given-names></name><name><surname>Appolloni</surname><given-names>I</given-names></name><name><surname>Pellegatta</surname><given-names>S</given-names></name><name><surname>Sanga</surname><given-names>AB</given-names></name><name><surname>Pagella</surname><given-names>P</given-names></name><name><surname>Gambini</surname><given-names>E</given-names></name><name><surname>Pisati</surname><given-names>F</given-names></name><name><surname>Ottolenghi</surname><given-names>S</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name><name><surname>Finocchiaro</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma</article-title><source>Cancer Res</source><volume>74</volume><fpage>1833</fpage><lpage>1844</lpage><year>2014</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1942</pub-id><pub-id pub-id-type="pmid">24599129</pub-id></element-citation></ref>
<ref id="b43-or-34-02-0920"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MC</given-names></name><name><surname>Cui</surname><given-names>FJ</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name></person-group><article-title>Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells</article-title><source>Asian Pac J Cancer Prev</source><volume>14</volume><fpage>3625</fpage><lpage>3630</lpage><year>2013</year><pub-id pub-id-type="doi">10.7314/APJCP.2013.14.6.3625</pub-id><pub-id pub-id-type="pmid">23886156</pub-id></element-citation></ref>
<ref id="b44-or-34-02-0920"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name></person-group><article-title>SOD2 is a C-myc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stem-like cells</article-title><source>Int J Biochem Cell Biol</source><volume>60</volume><fpage>139</fpage><lpage>146</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.biocel.2014.12.022</pub-id><pub-id pub-id-type="pmid">25578561</pub-id></element-citation></ref>
<ref id="b45-or-34-02-0920"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>CN</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Seo</surname><given-names>JS</given-names></name></person-group><article-title>Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species</article-title><source>J Cell Biochem</source><volume>100</volume><fpage>474</fpage><lpage>486</lpage><year>2007</year><pub-id pub-id-type="doi">10.1002/jcb.21064</pub-id></element-citation></ref>
<ref id="b46-or-34-02-0920"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruggeri</surname><given-names>P</given-names></name><name><surname>Farina</surname><given-names>AR</given-names></name><name><surname>Di Ianni</surname><given-names>N</given-names></name><name><surname>Cappabianca</surname><given-names>L</given-names></name><name><surname>Ragone</surname><given-names>M</given-names></name><name><surname>Ianni</surname><given-names>G</given-names></name><name><surname>Gulino</surname><given-names>A</given-names></name><name><surname>Mackay</surname><given-names>AR</given-names></name></person-group><article-title>The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype</article-title><source>PLoS One</source><volume>9</volume><fpage>e94568</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pone.0094568</pub-id><pub-id pub-id-type="pmid">24736663</pub-id><pub-id pub-id-type="pmcid">3988074</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-or-34-02-0920" position="float">
<label>Figure 1</label>
<caption>
<p>Cellular morphology under different cell culture conditions. (A) Cells were cultured for 72 h and cellular morphology was observed with an inverted phase contrast microscope. Cells were imaged after 4 h (B) or 24 h (C) of seeding on NP under different conditions. Scale bar indicates 200 <italic>&#x000B5;</italic>m.</p></caption>
<graphic xlink:href="OR-34-02-0920-g00.tif"/>
<graphic xlink:href="OR-34-02-0920-g01.tif"/>
<graphic xlink:href="OR-34-02-0920-g02.tif"/></fig>
<fig id="f2-or-34-02-0920" position="float">
<label>Figure 2</label>
<caption>
<p>Cell viability, cell cycle and western blotting. Cells were analyzed as described in the Materials and methods after culturing for 72 h. (A) Relative activity was compared to the viability of cells in Nm on NP. Data were derived from three independent experiments and reported as means &#x000B1; SE. <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. Nm on the NP group; <sup>#</sup>P&lt;0.05 vs. Nm on the same plate. (B) The cell cycle distribution was analyzed by flow cytometry. The graph is based on three independent measurements.</p></caption>
<graphic xlink:href="OR-34-02-0920-g03.tif"/></fig>
<fig id="f3-or-34-02-0920" position="float">
<label>Figure 3</label>
<caption>
<p>Expression of stemness- and EMT-related genes under different cell culture conditions. qRT-PCR analysis was carried out with the specific primers described in <xref rid="tI-or-34-02-0920" ref-type="table">Table I</xref>. Data are reported as means &#x000B1; SE from three independent experiments. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.05 vs. Nm on the NP group.</p></caption>
<graphic xlink:href="OR-34-02-0920-g04.tif"/></fig>
<fig id="f4-or-34-02-0920" position="float">
<label>Figure 4</label>
<caption>
<p>Measurements of ROS generation under different cell culture conditions. (A) Cells were analyzed by flow cytometry, represented as a histogram and overlaid with the histograms for the cells cultured under different conditions. (B) The percentage of positive fluorescent cells was obtained using Cell Quest software and is represented as fold change. Data are reported as means &#x000B1; SE from three independent experiments. <sup>&#x0002A;</sup>P&lt;0.05, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. Nm on the NP group; <sup>#</sup>P&lt;0.05 vs. Nm on the same plate.</p></caption>
<graphic xlink:href="OR-34-02-0920-g05.tif"/></fig>
<fig id="f5-or-34-02-0920" position="float">
<label>Figure 5</label>
<caption>
<p>Protein levels of SOX-2, SOD1, and SOD2 for different cell culture conditions. (A&#x02013;C) Protein levels were analyzed by western blotting using specific antibodies. Protein expression levels of the cells were analyzed using Image J software. The expression ratio relative to the control was calculated after compensating for the intensity of &#x003B2;-actin from each group. Data are reported as means &#x000B1; SE from three independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. Nm on the NP group; <sup>#</sup>P&lt;0.05 vs. Nm on the same plate. (D) Dot plot analysis was performed using the mean protein levels shown in A and C. The gray-dotted circle indicates the significantly increased SOX2-expressing group. The black ellipse indicates the SOD2-expressing group.</p></caption>
<graphic xlink:href="OR-34-02-0920-g06.tif"/></fig>
<fig id="f6-or-34-02-0920" position="float">
<label>Figure 6</label>
<caption>
<p>Treatment with NAC did not block increased protein levels of SOX-2, SOD1 or SOD2 under different culture conditions. (A&#x02013;C) Cells incubated with 10 mM NAC were maintained for 72 h and western blotting analysis was performed using specific antibodies. Data are reported as means &#x000B1; SE from three independent experiments.</p></caption>
<graphic xlink:href="OR-34-02-0920-g07.tif"/></fig>
<table-wrap id="tI-or-34-02-0920" position="float">
<label>Table I</label>
<caption>
<p>Primers for quantitative real-time PCR.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">Sequence (5&#x02032;-3&#x02032;)</th>
<th valign="top" align="center">Product (bp)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">SOX-2</td>
<td valign="top" align="left">Forward: 5&#x02032;-TACCTCTTCCTCCCACTCCA-3&#x02032;<break/>Reverse: 5&#x02032;-ACTCTCCTCTTTTGCACCCC-3&#x02032;</td>
<td valign="top" align="center">268</td></tr>
<tr>
<td valign="top" align="left">Nestin</td>
<td valign="top" align="left">Forward: 5&#x02032;-CGGTGGCTCCAAGACTTCC-3&#x02032;<break/>Reverse: 5&#x02032;-GGCACAGGTGTCTCAAGGGTA-3&#x02032;</td>
<td valign="top" align="center">156</td></tr>
<tr>
<td valign="top" align="left">OCT-4</td>
<td valign="top" align="left">Forward: 5&#x02032;-CAGCGACTATGCACAACGAGA-3&#x02032;<break/>Reverse: 5&#x02032;-GCCCAGAGTGGTGACGGA-3&#x02032;</td>
<td valign="top" align="center">196</td></tr>
<tr>
<td valign="top" align="left">CD133</td>
<td valign="top" align="left">Forward: 5&#x02032;-ACCCAACATCATCCCTGTTCTT-3&#x02032;<break/>Reverse: 5&#x02032;-AGCTCTTCAAGGTGCTGTTCATG-3&#x02032;</td>
<td valign="top" align="center">100</td></tr>
<tr>
<td valign="top" align="left">SNAIL</td>
<td valign="top" align="left">Forward: 5&#x02032;-CCTCCCTGTCAGATGAGGAC-3&#x02032;<break/>Reverse: 5&#x02032;-CCAGGCTGAGGTATTCCTTG-3&#x02032;</td>
<td valign="top" align="center">235</td></tr>
<tr>
<td valign="top" align="left">ZEB1</td>
<td valign="top" align="left">Forward: 5&#x02032;-GCCAATAAGCAAACGATTCTG-3&#x02032;<break/>Reverse: 5&#x02032;-TTTGGCTGGATCACTTTCAAG-3&#x02032;</td>
<td valign="top" align="center">100</td></tr>
<tr>
<td valign="top" align="left">ZEB2</td>
<td valign="top" align="left">Forward: 5&#x02032;-TTCCTGGGCTACGACCATAC-3&#x02032;<break/>Reverse: 5&#x02032;-TGTGCTCCATCAAGCAATTC-3&#x02032;</td>
<td valign="top" align="center">159</td></tr>
<tr>
<td valign="top" align="left">TWIST</td>
<td valign="top" align="left">Forward: 5&#x02032;-GGAGTCCGCAGTCTTACGAG-3&#x02032;<break/>Reverse: 5&#x02032;-TCTGGAGGACCTGGTAGAGG-3&#x02032;</td>
<td valign="top" align="center">200</td></tr>
<tr>
<td valign="top" align="left">SLUG</td>
<td valign="top" align="left">Forward: 5&#x02032;-GGGGAGAAGCCTTTTTCTTG-3&#x02032;<break/>Reverse: 5&#x02032;-TCCTCATGTTTGTGCAGGAG-3&#x02032;</td>
<td valign="top" align="center">157</td></tr>
<tr>
<td valign="top" align="left">N-cadherin</td>
<td valign="top" align="left">Forward: 5&#x02032;-ACAGTGGCCACCTACAAAGG-3&#x02032;<break/>Reverse: 5&#x02032;-CCGAGATGGGGTTGATAATG-3&#x02032;</td>
<td valign="top" align="center">200</td></tr>
<tr>
<td valign="top" align="left">Vimentin</td>
<td valign="top" align="left">Forward: 5&#x02032;-GAGAACTTTGCCGTTGAAGC-3&#x02032;<break/>Reverse: 5&#x02032;-GCTTCCTGTAGGTGGCAATC-3&#x02032;</td>
<td valign="top" align="center">162</td></tr>
<tr>
<td valign="top" align="left">&#x003B2;-actin</td>
<td valign="top" align="left">Forward: 5&#x02032;-AGTACTCCGTGTGGATCGGC-3&#x02032;<break/>Reverse: 5&#x02032;-GCTGATCCACATCTGCTGGA-3&#x02032;</td>
<td valign="top" align="center">67</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-or-34-02-0920">
<p>SOX2, SRY (sex determining region Y)-box 2; OCT4, octamer-binding transcription factor 4; SNAIL, SNAI1; ZEB1, zinc finger E-box-binding homeobox 1; ZEB2, zinc finger E-box-binding homeobox 2.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
